Uncoupling of protein kinase D from suppression of EGF-dependent c-Jun phosphorylation in cancer cells.

[1]  E. Rozengurt,et al.  Protein kinase D complexes with C-Jun N-terminal kinase via activation loop phosphorylation and phosphorylates the C-Jun N-terminus , 2002, Oncogene.

[2]  E. Rozengurt,et al.  Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. , 2002, Cancer research.

[3]  Peter Storz,et al.  Protein Kinase C (PKC)η-mediated PKCμ Activation Modulates ERK and JNK Signal Pathways* , 2002, The Journal of Biological Chemistry.

[4]  E. Rozengurt,et al.  Protein Kinase D Potentiates DNA Synthesis and Cell Proliferation Induced by Bombesin, Vasopressin, or Phorbol Esters in Swiss 3T3 Cells* , 2001, The Journal of Biological Chemistry.

[5]  E. Rozengurt,et al.  Activation of Protein Kinase D by Signaling through Rho and the α Subunit of the Heterotrimeric G Protein G13 * , 2001, The Journal of Biological Chemistry.

[6]  S. H. Young,et al.  Rapid Protein Kinase D Translocation in Response to G Protein-coupled Receptor Activation , 2001, The Journal of Biological Chemistry.

[7]  M. Tatsuta,et al.  Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. , 2001, Cancer research.

[8]  R. Murphy,et al.  Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions , 2001, British Journal of Cancer.

[9]  E. Rozengurt,et al.  Protein kinase D is sufficient to suppress EGF-induced c-Jun Ser 63 phosphorylation. , 2001, Biochemical and biophysical research communications.

[10]  P. Storz,et al.  Protein kinase C μ selectively activates the mitogen‐activated protein kinase (MAPK) p42 pathway , 2001, FEBS letters.

[11]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[12]  Peter Gierschik,et al.  Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration , 2000, Oncogene.

[13]  D. Bar-Sagi,et al.  Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. , 2000, Science.

[14]  E. Rozengurt,et al.  Lysophosphatidic acid rapidly induces protein kinase D activation through a pertussis toxin-sensitive pathway. , 2000, American journal of physiology. Cell physiology.

[15]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[16]  A. Ullrich,et al.  Cell‐type specific phosphorylation of threonines T654 and T669 by PKD defines the signal capacity of the EGF receptor , 1999, The EMBO journal.

[17]  T. Seufferlein,et al.  Transforming growth factor alpha activates Ha-Ras in human pancreatic cancer cells with Ki-ras mutations. , 1999, Gastroenterology.

[18]  O. Potapova,et al.  The Jun Kinase 2 Isoform Is Preferentially Required for Epidermal Growth Factor-Induced Transformation of Human A549 Lung Carcinoma Cells , 1999, Molecular and Cellular Biology.

[19]  D. Mercola,et al.  The JUN Kinase/Stress-activated Protein Kinase Pathway Is Required for Epidermal Growth Factor Stimulation of Growth of Human A549 Lung Carcinoma Cells* , 1997, The Journal of Biological Chemistry.

[20]  E. Rozengurt,et al.  Bombesin, Vasopressin, Endothelin, Bradykinin, and Platelet-derived Growth Factor Rapidly Activate Protein Kinase D through a Protein Kinase C-dependent Signal Transduction Pathway* , 1997, The Journal of Biological Chemistry.

[21]  E. Rozengurt,et al.  Bryostatin 1 Induces Biphasic Activation of Protein Kinase D in Intact Cells* , 1997, The Journal of Biological Chemistry.

[22]  M. Büchler,et al.  Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum , 1996, International journal of cancer.

[23]  E. Rozengurt,et al.  Protein kinase D (PKD) activation in intact cells through a protein kinase C‐dependent signal transduction pathway. , 1996, The EMBO journal.

[24]  M. Asaka,et al.  An effect of K‐ras gene mutation on epidermal growth factor receptor signal transduction in PANC‐1 pancreatic carcinoma cells , 1996, International journal of cancer.

[25]  R. Evans,et al.  Ecdysone-inducible gene expression in mammalian cells and transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Korc,et al.  Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters. , 1996, Carcinogenesis.

[27]  H. Friess,et al.  Cellular and subcellular localization of transforming growth factor-alpha and epidermal growth factor receptor in normal and diseased human and hamster pancreas. , 1995, Teratogenesis, carcinogenesis, and mutagenesis.

[28]  J. Chen,et al.  Expression of EGF, TGF-alpha, EGFR and c-erbB2 genes and their gene products in human pancreatic carcinoma cell lines. , 1994, Zentralblatt fur Pathologie.

[29]  H. Friess,et al.  Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. , 1993, Anticancer research.

[30]  M. Karin,et al.  Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73 , 1991, Nature.

[31]  M. Korc,et al.  Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. , 1987, Proceedings of the National Academy of Sciences of the United States of America.